Examples of IGF in the following topics:
-
- Body growth is controlled by growth hormone (GH), produced by the anterior pituitary, and IGF-1, whose production is stimulated by GH.
- GH also stimulates, through another pathway, the production of insulin-like growth factor 1 (IGF-1), a hormone homologous to proinsulin.
- The liver, a major target organ of GH for this process, is the principal site of IGF-1 production.
- IGF-1 has growth-stimulating effects on a wide variety of tissues.
- IGF-1 also has stimulatory effects on osteoblast and chondrocyte activity to promote bone growth.
-
- Somatopause is a term used to describe the change in GH/IGF-I axis, which involves a decrease in production and sensitivity to GH and IGF-I.
- Decreases in IGF-I signaling, GH deficiency, and GH resistance cause delayed aging and extended lifespan in animal models, in sharp contrast to the effects of GH/IGF-I in humans.
- The reason for the opposing actions of GH/IGF-I in different species is not presently understood.
- In addition to lower circulating amounts of IGF-I, the responsiveness of bone to this protein has been shown to decrease in animal models.
- This can be attributed to a decrease in IGF-I signaling pathways with advanced cell age.
-
- The liver also produces the insulin-like growth factor 1 (IGF-1), a polypeptide protein hormone that plays an important role in childhood growth and continues to have anabolic effects in adults.
-
- Both processes utilize cytokine (TGF-β, IGF) signaling.
-
- Both processes utilize cytokine (TGF-β, IGF) signalling.
-
- Increased levels of Insulin Growth Factor-1 (IGF-1) have been correlated to vertex balding.
-
- Once the effector glands produce sufficient hormones (thyroxine, cortisol, estradiol or testosterone and IGF-1), both the hypothalamus and the pituitary cells sense their abundance and reduce their secretion of stimulating hormones.